Gastroenterology Endpoints For IBD Drugs Once Again In FDA Spotlight
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is holding another workshop to discuss selection of endpoints in development of drugs to treat pediatric and adult inflammatory bowel diseases; the agency held four gastroenterology workshops last year.